3 Crucial Questions Johnson & Johnson Needs to Answer

Here are three things investors need to know post-earnings.

Michael Douglass
Michael Douglass and Dave Williamson
Jul 18, 2014 at 5:00PM
Health Care

Mr. Market's non-response notwithstanding, Johnson & Johnson (NYSE:JNJ) turned in a great second quarter. But with any company as big as J&J, not every investor question can be answered, and sometimes the leftover question marks are pretty big.

Below are three crucial questions Motley Fool health care analysts Michael Douglass and David Williamson think J&J still needs to answer.